Aerovate Therapeutics Inc.
13F holders, Q3 2024 (September 30)75holders −6
12new positions
20sold out
3famous investors
$2.09avg. 13F price*
At the end of Q3 2024, 75 institutions reported holding Aerovate Therapeutics Inc. in their 13F filings, down 6 from Q2 2024. 12 opened new positions and 20 sold out. The largest holders were Ra Capital Management, L.P. ($19.2M), Sofinnova Investments, Inc. ($7.9M) and TCG Crossover Management, LLC ($4.7M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Cliff Asness (0.0% of AQR Capital Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aerovate Therapeutics Inc.
- CUSIP
- 008064107
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $2.1M |
| Exits | 20 | $2.0M |
All 13F filers, Q2 2024 → Q3 2024: 2,804,724 shares bought and 2,312,898 shares sold, net +491,826 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 75 holders
| Ra Capital Management, L.P. | 0.22% | No change | 9,192,092 | $19.2M |
| Sofinnova Investments, Inc. | 0.65% | No change | 3,758,686 | $7.9M |
| TCG Crossover Management, LLC | 0.40% | No change | 2,240,809 | $4.7M |
| Atlas Venture Life Science Advisors, LLC | 0.35% | No change | 1,799,232 | $3.8M |
| Deerfield Management Company, L.P. | 0.05% | No change | 1,411,608 | $3.0M |
| Vanguard Group Inc. | 0.00% | Add +4.2% | 1,151,873 | $2.4M |
| BlackRock, Inc. | 0.00% | — | 953,676 | $2.0M |
| Baker Bros. Advisors LP | 0.01% | No change | 628,939 | $1.3M |
| Affinity Asset Advisors, LLC | 0.21% | Add +200.0% | 600,000 | $1.3M |
| Eversept Partners, LP | 0.08% | New | 485,141 | $1.0M |
| Octagon Capital Advisors LP | 0.16% | No change | 465,440 | $973K |
| Opaleye Management Inc. | 0.16% | No change | 440,000 | $920K |
| Gsa Capital Partners LLP | 0.07% | Add +226.8% | 413,795 | $865K |
| Ikarian Capital, LLC | 0.24% | No change | 367,965 | $769K |
| State Street Corp. | 0.00% | Add +7.7% | 367,468 | $768K |
| Acadian Asset Management LLC | 0.00% | New | 359,376 | $750K |
| Morgan Stanley | 0.00% | Add +545.1% | 333,968 | $698K |
| Two Sigma Investments, LP | 0.00% | Add +12.3% | 313,114 | $654K |
| Geode Capital Management, LLC | 0.00% | Reduce -8.0% | 291,887 | $610K |
| Bank of America Corp. | 0.00% | Add +1262.4% | 261,031 | $546K |
| Citigroup Inc. | 0.00% | Add +6484.2% | 233,411 | $488K |
| Millennium Management | 0.00% | Reduce -69.4% | 196,644 | $411K |
| Goldman Sachs Group Inc. | 0.00% | Add +77.0% | 161,011 | $337K |
| ADAR1 Capital Management, LLC | 0.04% | Reduce -54.2% | 113,075 | $236K |
| Two Sigma Advisers, LP | 0.00% | Add +58.9% | 110,900 | $232K |
| Northern Trust Corp. | 0.00% | Add +4.9% | 100,396 | $210K |
| Verition Fund Management LLC | 0.00% | Reduce -59.9% | 99,815 | $209K |
| Boothbay Fund Management, LLC | 0.01% | Reduce -11.3% | 97,842 | $204K |
| FMR LLC | 0.00% | Add +54095.4% | 82,919 | $173K |
| Alliancebernstein L.P. | 0.00% | No change | 69,910 | $146K |
| Voya Investment Management LLC | 0.00% | New | 65,659 | $137K |
| Nan Fung Group Holdings Ltd | 0.09% | No change | 47,936 | $100K |
| AQR Capital Management | 0.00% | New | 45,343 | $95K |
| Bank of New York Mellon Corp | 0.00% | Reduce -11.8% | 41,466 | $87K |
| Nuveen Asset Management, LLC | 0.00% | No change | 40,047 | $84K |
| Bank of Montreal | 0.00% | New | 31,644 | $65K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -43.6% | 29,351 | $61K |
| State of Wisconsin Investment Board | 0.00% | Add +16.5% | 29,009 | $61K |
| ExodusPoint Capital Management, LP | 0.00% | Reduce -2.8% | 21,105 | $44K |
| Barclays PLC | 0.00% | Add +310.8% | 18,972 | $40K |
| Renaissance Technologies | 0.00% | New | 17,900 | $37K |
| Jane Street Group, LLC | 0.00% | Reduce -83.8% | 17,805 | $37K |
| Rhumbline Advisers | 0.00% | Reduce -12.1% | 13,266 | $28K |
| SG Americas Securities, LLC | 0.00% | Reduce -93.9% | 11,018 | $23K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -9.0% | 10,579 | $22K |
| Balyasny Asset Management L.P. | 0.00% | New | 10,235 | $21K |
| Corsair Capital Management, L.P. | 0.01% | Reduce -49.8% | 10,100 | $21K |
| Group One Trading LLC | 0.00% | Add +253.4% | 9,917 | $21K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +52.4% | 7,438 | $16K |
| Corebridge Financial, Inc. | 0.00% | Reduce -0.6% | 7,211 | $15K |
| Russell Investments Group, Ltd. | 0.00% | New | 7,207 | $15K |
| UBS Group AG | 0.00% | Reduce -42.6% | 6,344 | $13K |
| JPMorgan Chase & Co. | 0.00% | Add +2.8% | 5,991 | $13K |
| Federated Hermes, Inc. | 0.00% | Add +577.3% | 5,283 | $11K |
| Wells Fargo & Company | 0.00% | Reduce -3.2% | 4,898 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +17.7% | 4,881 | $10K |
| Simplex Trading, LLC | 0.00% | Reduce -14.2% | 5,022 | $10K |
| New York State Common Retirement Fund | 0.00% | No change | 4,294 | $9K |
| Virtus Advisers, LLC | 0.00% | Add +1.8% | 3,749 | $8K |
| STRS Ohio | 0.00% | No change | 2,200 | $5K |
| Royal Bank of Canada | 0.00% | Add +63.4% | 2,080 | $4K |
| Legal & General Group Plc | 0.00% | No change | 1,128 | $2K |
| California State Teachers Retirement System | 0.00% | No change | 977 | $2K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 772 | $2K |
| Amalgamated Bank | 0.00% | No change | 347 | $1K |
| Cwm, LLC | 0.00% | Add +307.4% | 497 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | Add +809.1% | 200 | $418 |
| Arax Advisory Partners | 0.00% | No change | 117 | $245 |
| Jones Financial Companies LLLP | 0.00% | No change | 100 | $206 |
| Earned Wealth Advisors, LLC | 0.00% | New | 80 | $167 |
| Rothschild Investment LLC | 0.00% | New | 70 | $146 |
| Deutsche Bank AG | 0.00% | Reduce -100.0% | 17 | $36 |
| Sterling Capital Management LLC | 0.00% | — | 13 | $27 |
| Capital Advisors, Ltd. LLC | 0.00% | New | 8 | $0 |
| Avion Wealth | 0.00% | New | 258 | $0 |
"% of holder's portfolio" is AEROVATE THERAPEUTICS INC's weight in each manager's 13F, not the share of Aerovate Therapeutics Inc. the manager owns.